Numerous studies have consistently shown that increased plasma levels of cytokines, including IL‐1, IL‐6, and IL‐12 are strongly associated with severe lung inflammation in individuals with COVID‐19 pneumonia, leading to an increased risk of mortality [26, 27]. Here, IL6 is linked to inflammatory response.